Benzinga's Top Downgrades
Analysts at Ascendiant downgraded POZEN (NASDAQ: POZN) from “strong buy” to “neutral.” The target price for POZEN is set to $10. POZEN's shares closed at $9.77 on Friday.
JMP Securities downgraded Myriad Genetics (NASDAQ: MYGN) from “market perform” to “underperform.” The target price for Myriad Genetics is set to $15. Myriad Genetics' shares closed at $24.14 on Friday.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.